U.S. approves new Moderna COVID vaccine, but for narrow group of people

Moderna wins narrower US approval for new COVID vaccine Moderna Inc. gained U.S. approval for a new COVID vaccine for a narrower group of people, in the latest sign that regulators are restricting access to immunizations under the leadership of Health and ... Gerry Smith Medical Xpress

Moderna  gained U.S. approval for a new COVID vaccine for a narrower group of people, in the latest sign that regulators are restricting access to immunizations under the leadership of Health and Human Services Secretary Robert F. Kennedy Jr.

The company's second-generation vaccine is cleared for all adults over 65 and anyone over 12 who has at least one risk factor for severe disease, Moderna said in a statement Saturday. Moderna's COVID shot had previously been approved for people 12 years of age and older regardless of their underlying health.

...